Literature DB >> 26268730

Antibiotic Policies and Utilization in Oregon Hospice Programs.

Rachel L Novak1, Brie N Noble1, Erik K Fromme2, Michael O Tice1, Jessina C McGregor1, Jon P Furuno3.   

Abstract

Antibiotics are frequently used in hospice care, despite limited data on safety and effectiveness in this patient population. We surveyed Oregon hospice programs on antibiotic policies and prescribing practices. Among 39 responding hospice programs, the median reported proportion of current census using antibiotics was 10% (interquartile range = 3.5%-20.0%). Approximately 31% of responding hospice programs had policies for antibiotic initiation, 17% of hospice programs had policies for antibiotic discontinuation, and 95% of hospice programs had policies for managing drug interactions. Diarrhea, nausea/vomiting, and yeast infections were the most frequently reported antibiotic-associated adverse events, occurring "sometimes" or "often" among 62%, 47%, and 62% of respondents, respectively. In conclusion, less than a third of participating hospice programs reported having a policy for antibiotic initiation and even less frequently a policy for discontinuation. More data are needed on the risks and benefits of antibiotic use in hospice care to inform these policies and optimize outcomes in this vulnerable patient population.
© The Author(s) 2015.

Entities:  

Keywords:  adverse events; antibiotics; hospice; infection; medications; policies; survey

Mesh:

Substances:

Year:  2015        PMID: 26268730     DOI: 10.1177/1049909115599951

Source DB:  PubMed          Journal:  Am J Hosp Palliat Care        ISSN: 1049-9091            Impact factor:   2.500


  2 in total

1.  Antibiotic stewardship program (ASP) in palliative care: antibiotics, to give or not to give.

Authors:  Kai Chee Hung; Lai Wei Lee; Yi Xin Liew; Lalit Krishna; Maciej Piotr Chlebicki; Shimin Jasmine Chung; Andrea Lay-Hoon Kwa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-08-20       Impact factor: 3.267

2.  Long-Acting Lipoglycopeptides for Gram-Positive Bacteremia at the End of Life to Facilitate Hospice Care: A Report of 3 Cases.

Authors:  Rupak Datta; Dayna McManus; Jeffrey Topal; Manisha Juthani-Mehta
Journal:  Open Forum Infect Dis       Date:  2018-01-27       Impact factor: 3.835

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.